NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

3 sessions about the use of External Controls in Glioblastoma trials at the first Annual Conference on CNS Clinical Trials, Co-Sponsored by SNO and @ASCO, being held virtually today and tomorrow, starts at 11am EDT.

There is still time to register: https://bit.ly/SNOASCO

Saturday, October 2, 2021
11:00am – 4:25pm EDT

1:05am-11:25am
Keynote: Regulatory Considerations for the Treatment of CNS Tumors: Past, Present and Future

Amy Barone, US Food & Drug Administration

SESSION 3: Clinical Research Methods in 21st Century

2:20pm - 2:35pm
Leveraging External Data in Design and Analysis of Clinical Trials in Glioblastoma
Rifaquat Rahman, Dana Farber/Brigham and Women’s Cancer Center

3:00pm - 3:10pm
Abstract CLRM-12: Hybrid Designs for Using External Controls in Phase 3 Glioblastoma Trials
Daniel Schwartz, University of Chicago

3:10pm - 3:20pm
Abstract CLRM-09: Incorporating External Control Arm in MDNA55 Recurrent Glioblastoma Registration Trial
Ruthanna Davi, Medidata Acorn AI

https://www.soc-neuro-onc.org/UploadedFiles/Program_Clinical%20Trials%202021%20for%20website-%20October%201.pdf
https://twitter.com/NeuroOnc

The Lancet Oncology
SERIES|
CANCER TRIALS AND DESIGN PRINCIPLES
VOLUME 22, ISSUE 10, E456-E465, OCTOBER 01, 2021
Published:October, 2021

Leveraging external data in the design and analysis of clinical trials in neuro-oncology
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00488-5/fulltext

Rifaquat Rahman, MD
Steffen Ventz, PhD
Jon McDunn, PhD
Bill Louv, PhD
Irmarie Reyes-Rivera, PhD
Mei-Yin C Polley, PhD
Fahar Merchant, PhD
Lauren E Abrey, MD
Joshua E Allen, PhD
Laura K Aguilar, MD
Estuardo Aguilar-Cordova, MD
David Arons, JD
Kirk Tanner, PhD
Stephen Bagley, MD
Mustafa Khasraw, MD
Prof Timothy Cloughesy, MD
Prof Patrick Y Wen, MD
Brian M Alexander, MD
Lorenzo Trippa, PhD